Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate
AUTOR(ES)
MacDougall, Lori D.
RESUMO
A male, neutered cat was presented for lethargy, reluctance to walk, and mammary enlargement after recent treatment with megestrol acetate. Mammary fibroadenomatous hyperplasia was diagnosed on the basis of history, clinical signs, and histopathological findings. Pathogenesis, clinical signs, and treatment options for mammary fibroadenomatous hyperplasia attributed to megestrol acetate treatment are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=340082Documentos Relacionados
- Treatment with Megestrol Acetate Improves Human Immunodeficiency Virus-Associated Immune Thrombocytopenia
- Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients.
- Hypospadias associated with the use of high dose megestrol acetate in an HIV infected woman.
- Blindness now attributed to enrofloxacin therapy in a previously reported case of a cat with acromegaly treated by cryohypophysectomy
- Pseudoangiomatous hyperplasia of mammary stroma associated with gynaecomastia.
